What does this research mean for the field?

The prescription of warfarin, clopidogrel, or aspirin is associated with an increased risk of mortality among incident hemodialysis patients. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

March 18, 2009Journal of the American Society of NephrologyOpen Access

Anticoagulant and Antiplatelet Usage Associates with Mortality among Hemodialysis Patients

View Full Paper

Ask AI

Bookmark

Authors

KCKevin E. ChanNational Institute of Diabetes and Digestive and Kidney Diseases JLJ. Michael LazarusGroote Schuur Hospital RTRavi ThadhaniUniversity of Pisa

Discussion

Member takes

Implication

Warfarin, aspirin, or clopidogrel use was associated with higher mortality in HD patients; leaves open causality and optimal antithrombotic strategies.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chan et al. (2009) studied this question.

synapsesocial.com/papers/6a1e78c19eec3e6c3a55e934 https://doi.org/10.1681/asn.2008080824

Topics

Dual antiplatelet therapy Anticoagulation in AF

View Full Paper

Ask AI

Bookmark

Implication

Warfarin, aspirin, or clopidogrel use was associated with higher mortality in HD patients; leaves open causality and optimal antithrombotic strategies.

Anticoagulant and Antiplatelet Usage Associates with Mortality among Hemodialysis Patients

Discussion

Member takes

Implication

Key Points

Cite This Study

Topics

Anticoagulant and Antiplatelet Usage Associates with Mortality among Hemodialysis Patients

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Topics

Also Consider